Atria Investments LLC Genmab A/S Transaction History

Atria Investments LLC

$7.33 Billion
Q1 2025

A detailed history of Atria Investments LLC transactions in Genmab A/S stock. As of the latest transaction made, Atria Investments LLC holds 31,040 shares of GMAB stock, worth $645,942. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,040

Previous 29,301 5.93%

Holding current value

$645,942

Previous $611,000 0.65%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$18.69 - $24.14 $32,501 - $41,979	1,739 Added 5.93%	31,040 $607,000
Q4 2024 Feb 06, 2025	SELL	$20.02 - $24.15 $383,863 - $463,052	-19,174 Reduced 39.55%	29,301 $611,000
Q3 2024 Nov 01, 2024	BUY	$23.84 - $28.48 $343,868 - $410,795	14,424 Added 42.36%	48,475 $1.18 Million
Q2 2024 Aug 13, 2024	BUY	$25.13 - $30.27 $6,156 - $7,416	245 Added 0.72%	34,051 $855,000
Q1 2024 May 21, 2024	SELL	$26.43 - $32.77 $354,109 - $439,052	-13,398 Reduced 28.38%	33,806 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $215,361 - $273,171	-7,708 Reduced 14.04%	47,204 $1.5 Million
Q3 2023 Nov 07, 2023	BUY	$35.27 - $42.24 $679,088 - $813,288	19,254 Added 54.0%	54,912 $1.94 Million
Q2 2023 Aug 04, 2023	SELL	$37.4 - $42.94 $131,348 - $150,805	-3,512 Reduced 8.97%	35,658 $1.36 Million
Q1 2023 May 10, 2023	SELL	$34.88 - $43.22 $237,846 - $294,717	-6,819 Reduced 14.83%	39,170 $1.48 Million
Q4 2022 Jan 31, 2023	SELL	$33.8 - $47.06 $143,278 - $199,487	-4,239 Reduced 8.44%	45,989 $1.95 Million
Q3 2022 Nov 01, 2022	BUY	$31.52 - $373.61 $1.58 Million - $18.8 Million	50,228 New	50,228 $1.61 Million
Q2 2022 Aug 11, 2022	SELL	$26.83 - $38.57 $814,183 - $1.17 Million	-30,346 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$30.95 - $39.68 $178,426 - $228,755	-5,765 Reduced 15.96%	30,346 $1.1 Million
Q4 2021 Feb 04, 2022	SELL	$35.87 - $47.12 $62,915 - $82,648	-1,754 Reduced 4.63%	36,111 $1.43 Million
Q3 2021 Nov 16, 2021	BUY	$41.55 - $48.72 $506,411 - $593,799	12,188 Added 47.47%	37,865 $1.66 Million
Q2 2021 Aug 10, 2021	BUY	$32.88 - $44.57 $844,259 - $1.14 Million	25,677 New	25,677 $1.05 Million
Q1 2021 May 11, 2021	SELL	$30.92 - $44.4 $980,565 - $1.41 Million	-31,713 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $33,962 - $41,126	1,009 Added 3.29%	31,713 $1.29 Million
Q3 2020 Nov 05, 2020	SELL	$33.07 - $38.68 $127,352 - $148,956	-3,851 Reduced 11.14%	30,704 $1.12 Million
Q2 2020 Sep 22, 2020	BUY	$20.05 - $33.89 $692,827 - $1.17 Million	34,555 New	34,555 $1.17 Million
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $429,864 - $632,139	-25,065 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$18.88 - $24.14 $473,227 - $605,069	25,065 New	25,065 $560,000

Others Institutions Holding GMAB

# of Institutions

247

Shares Held

66.2M

Call Options Held

729K

Put Options Held

398K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.7B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Genmab A/S Transaction History